{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:36:33Z","timestamp":1754145393215,"version":"3.41.2"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UC2AR081029"],"award-info":[{"award-number":["UC2AR081029"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.rdc.2025.05.008","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:36:33Z","timestamp":1748964993000},"page":"417-431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis"],"prefix":"10.1016","volume":"51","author":[{"given":"Georgia","family":"Marquez-Grap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Kranyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rdc.2025.05.008_bib1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.008_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2025.05.008_bib3","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","article-title":"Treatment guidelines in psoriatic arthritis","volume":"59","author":"Ogdie","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.008_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/acr.20401","article-title":"Incidence of arthritis in a prospective cohort of psoriasis patients","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2025.05.008_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-224148","article-title":"EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis","author":"Zabotti","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.008_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.008_bib7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/rheumatology\/keab622","article-title":"Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study","volume":"61","author":"Ogdie","year":"2022","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.008_bib8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/13543784.2024.2383421","article-title":"Early psoriatic arthritis: clinical and therapeutic challenges","volume":"33","author":"Caso","year":"2024","journal-title":"Expet Opin Invest Drugs"},{"issue":"11","key":"10.1016\/j.rdc.2025.05.008_bib9","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s13555-023-01025-8","article-title":"Prevalence of musculoskeletal symptoms in patients with psoriasis and predictors associated with the development of psoriatic arthritis: retrospective analysis of a US claims database","volume":"13","author":"Merola","year":"2023","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.008_bib10","first-page":"1856","article-title":"Risk factors for psoriatic arthritis development in psoriasis patients: myths, pitfalls, and pearls","volume":"42","author":"Patt","year":"2024","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.008_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","article-title":"Obesity and psoriatic arthritis: a narrative review","volume":"7","author":"Kumthekar","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.rdc.2025.05.008_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/OARRR.S331859","article-title":"New perspectives on diagnosing psoriatic arthritis by imaging techniques","volume":"13","author":"Sarbu","year":"2021","journal-title":"Open Access Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.008_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101690","article-title":"Imaging in psoriatic arthritis: status and recent advances","volume":"35","author":"Mathew","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2025.05.008_bib14","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.008_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001067","article-title":"Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia","volume":"5","author":"Zabotti","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.rdc.2025.05.008_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241288060","article-title":"Imaging in psoriatic arthritis: established methods and emerging techniques","volume":"16","author":"Jin","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13075-018-1653-5","article-title":"Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study","volume":"20","author":"Kampylafka","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2025.05.008_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1054539","article-title":"Biomarkers in psoriatic arthritis: a meta-analysis and systematic review","volume":"13","author":"Wirth","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13075-021-02545-4","article-title":"Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review","volume":"23","author":"Mulder","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.008_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/bjd.18940","article-title":"Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?","volume":"183","author":"Abji","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.008_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.55133\/eji.310314","article-title":"Serum calprotectin as an inflammatory marker in psoriatic arthritis patients: relation to disease activity and musculoskeletal ultrasound findings","volume":"31","author":"Badr","year":"2024","journal-title":"Egypt J Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2025.05.008_bib22","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.41652","article-title":"Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2025.05.008_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9927964","article-title":"Circulating immune landscape profiling in psoriasis vulgaris and psoriatic arthritis by mass cytometry","volume":"2024","author":"Sang","year":"2024","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.008_bib24","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.16203","article-title":"Circulating micro RNA s in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis","volume":"34","author":"Pasquali","year":"2020","journal-title":"Acad Dermatol Venereol"},{"key":"10.1016\/j.rdc.2025.05.008_bib25","article-title":"Differential expression of plasma extracellular vesicle miRNAs as biomarkers for distinguishing psoriatic arthritis from psoriasis","author":"Yan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.rdc.2025.05.008_bib26","article-title":"Plasma proteins and psoriatic arthritis: a proteome-wide Mendelian randomization study","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.rdc.2025.05.008_bib27","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/rheumatology\/kep243","article-title":"A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study","volume":"48","author":"Karason","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.008_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2008.089367","article-title":"Familial aggregation of psoriatic arthritis","volume":"68","author":"Chandran","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.008_bib30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.rdc.2015.07.002","article-title":"Genetic, epigenetic and pharmacogenetic aspects of psoriasis and psoriatic arthritis","volume":"41","author":"O\u2019Rielly","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.rdc.2025.05.008_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2019.02.001","article-title":"Genetic and inflammatory factors associated with psoriatic arthritis: relevance to diagnosis and management","volume":"202","author":"Furst","year":"2019","journal-title":"Clin Immunol"},{"key":"10.1016\/j.rdc.2025.05.008_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.662047","article-title":"The molecular pathophysiology of psoriatic arthritis-the complex interplay between genetic predisposition, epigenetics factors, and the microbiome","volume":"8","author":"Carvalho","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"9","key":"10.1016\/j.rdc.2025.05.008_bib33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clinthera.2023.07.003","article-title":"Genetic studies investigating susceptibility to psoriatic arthritis: a narrative review","volume":"45","author":"Soomro","year":"2023","journal-title":"Clin Ther"},{"issue":"7488","key":"10.1016\/j.rdc.2025.05.008_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.008_bib35","article-title":"Clinical and molecular significance of genetic loci associated with psoriatic arthritis","volume":"35","author":"O\u2019Rielly","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/jpm12010035","article-title":"Advances of genomic medicine in psoriatic arthritis","volume":"12","author":"Laborde","year":"2022","journal-title":"J Personalized Med"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.008_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-021-00843-2","article-title":"Insights into the pathogenesis of psoriatic arthritis from genetic studies","volume":"43","author":"Rahmati","year":"2021","journal-title":"Semin Immunopathol"},{"issue":"23","key":"10.1016\/j.rdc.2025.05.008_bib38","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1111\/jcmm.15742","article-title":"Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes","volume":"24","author":"Caputo","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib39","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1038\/s41467-018-06672-6","article-title":"Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients","volume":"9","author":"Patrick","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.rdc.2025.05.008_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313344","article-title":"The shared biomarkers and immune landscape in psoriatic arthritis and rheumatoid arthritis: findings based on bioinformatics, machine learning and single-cell analysis","volume":"19","author":"Zhou","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.008_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s13075-014-0426-z","article-title":"Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?","volume":"16","author":"van Baarsen","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1\u20132","key":"10.1016\/j.rdc.2025.05.008_bib42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","article-title":"IL-17 receptor and its functional significance in psoriatic arthritis","volume":"359","author":"Raychaudhuri","year":"2012","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.008_bib43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis","volume":"67","author":"Belasco","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.008_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/1744666X.2017.1241710","article-title":"Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis","volume":"13","author":"Tan","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cyto.2015.01.019","article-title":"Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis","volume":"73","author":"Filkov\u00e1","year":"2015","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.rdc.2025.05.008_bib46","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.008_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128262","article-title":"Gene expression profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis","volume":"10","author":"Dolcino","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.rdc.2025.05.008_bib48","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2025.05.008_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.656667","article-title":"Synovial immunohistological biomarkers of the classification of undifferentiated arthritis evolving to rheumatoid or psoriatic arthritis","volume":"8","author":"Cuervo","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib51","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47310-5","article-title":"Increased frequency of activated CD8+ T cell effectors in patients with psoriatic arthritis","volume":"9","author":"Diani","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.rdc.2025.05.008_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/art.41156","article-title":"Polyfunctional, proinflammatory, tissue-resident memory phenotype and function of synovial interleukin-17A+CD8+ T cells in psoriatic arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2025.05.008_bib54","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.3390\/ijms22083998","article-title":"Alterations of the skin and gut microbiome in psoriasis and psoriatic arthritis","volume":"22","author":"Olejniczak-Staruch","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.rdc.2025.05.008_bib55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/ard-2022-223389","article-title":"Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin","volume":"82","author":"Boix-Amor\u00f3s","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2025.05.008_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2025.05.008_bib57","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947872","article-title":"Metabolic energy sensing by mammalian CLC anion\/proton exchangers","volume":"21","author":"Grieschat","year":"2020","journal-title":"EMBO Rep"},{"issue":"2","key":"10.1016\/j.rdc.2025.05.008_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.17745","article-title":"Evaluation of subclinical gut inflammation using faecal calprotectin levels and colonic mucosal biopsy in patients with psoriasis and psoriatic arthritis","volume":"181","author":"Adarsh","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.rdc.2025.05.008_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1342172","article-title":"Investigating causal associations among gut microbiota, metabolites, and psoriatic arthritis: a Mendelian randomization study","volume":"15","author":"Xu","year":"2024","journal-title":"Front Microbiol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X25000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X25000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:16:34Z","timestamp":1752711394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X25000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0889857X25000316"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2025.05.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2025.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}